TEV-278

N/A

Report date: 2024/12/18 16:55:05

Base Information

Drug NameTEV-278
Drug Alias NameTEV-‘278TEV-278
ClassificationBiologics
Mechanisms of ActionAnti-PD-1Interleukin-2 modulators
TargetsProgrammed cell death protein 1Interleukin-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A